We believe there is a more affordable way to deliver medicine.

Developing high quality, lower-cost respiratory and allergy therapies for a changing healthcare landscape.
Read more

Finding a way to put patients first.

We are committed to developing more affordable therapies so more patients have access to the medicine they need.
Read more

About Us

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy.

The mission of Adamis is to provide high quality, lower-cost alternatives to existing therapies in the allergy and respiratory areas to reach a broader range of patients.

Read more


SYMJEPI (epinephrine) Injection intends to compete as a lower-cost therapeutic epinephrine alternative in the anaphylaxis market.


Read more

Areas of Focus:
Allergy and Respiratory

Solutions for Change

Adamis is dedicated to advancing the therapeutic areas of respiratory diseases and allergies while providing affordable treatment solutions for anaphylaxis, asthma, and chronic obstructive pulmonary disease (COPD).

Read more